Semi-Annual Consolidated Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7722350

Concept 2018-04-01 to
2018-06-30
2017-04-01 to
2017-06-30
Semi-annual consolidated statement of income
Statement of income
Net sales
11,357,000,000 JPY
11,509,000,000 JPY
Cost of sales
8,011,000,000 JPY
8,194,000,000 JPY
Ordinary profit (loss)
363,000,000 JPY
278,000,000 JPY
Gross profit (loss)
3,345,000,000 JPY
3,314,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
3,087,000,000 JPY
3,168,000,000 JPY
Extraordinary losses
7,000,000 JPY
0 JPY
Profit (loss) before income taxes
355,000,000 JPY
277,000,000 JPY
Operating profit (loss)
258,000,000 JPY
145,000,000 JPY
Income taxes - current
10,000,000 JPY
8,000,000 JPY
Non-operating income
Interest income
5,000,000 JPY
5,000,000 JPY
Dividend income
42,000,000 JPY
38,000,000 JPY
Non-operating income
206,000,000 JPY
223,000,000 JPY
Income taxes - deferred
110,000,000 JPY
77,000,000 JPY
Non-operating expenses
Interest expenses
51,000,000 JPY
50,000,000 JPY
Non-operating expenses
100,000,000 JPY
91,000,000 JPY
Income taxes
120,000,000 JPY
85,000,000 JPY
Profit (loss)
235,000,000 JPY
192,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
3,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.